Bayer: Coronary Artery Disease trials
The registry lists 14 Coronary Artery Disease studies with Bayer as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 1 4Phase 2 2Phase 3 3No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery DiseaseNot yet recruitingNCT07431294Phase 1
- Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)CompletedNCT01890434Phase 3Results posted
- Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)CompletedNCT01890421Phase 3Results posted
- Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery DiseaseCompletedNCT01776424Phase 3Results posted
- A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the LegsCompletedNCT04401761
- Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)CompletedNCT04298567
- Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood VesselsCompletedNCT04097912
- Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic AcidCompletedNCT03746275
- Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory DataCompletedNCT03605810
- Study to Evaluate the QT / QTc Interval Prolongation Potential of VericiguatCompletedNCT03504982Phase 1
- Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease PatientsCompletedNCT03255512Phase 1
- Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease PatientsCompletedNCT02617550Phase 1
- Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary InterventionCompletedNCT01442792Phase 2
- Coronary Vasomotor Response After Riociguat ExposureWithdrawnNCT01165931Phase 2